Healthcare Decliners: Sorrento Therapeutics (NASDAQ:SRNE), Fibrocell Science (NYSEMKT:FCSC), TG Therapeutics (NASDAQ:TGTX), CombiMatrix (NASDAQ:CBMX)

Sorrento Therapeutics Inc (NASDAQ:SRNE) announced in a press release that the National Institutes of Health (NIH) has provided funding for the development of bispecific antibodies. Two small business grants from the NIH will allow Sorrento to use its antibody conjugation technology platform to develop antibodies for two of the NIH’s anti-bacterial immunotherapies. Sorrento’s pipeline also shows promise in anti-infectives and auto-immune diseases. Sorrento Therapeutics Inc … Continue reading Healthcare Decliners: Sorrento Therapeutics (NASDAQ:SRNE), Fibrocell Science (NYSEMKT:FCSC), TG Therapeutics (NASDAQ:TGTX), CombiMatrix (NASDAQ:CBMX)

Recent Insider Buying: American Realty Capital Properties (NASDAQ:ARCP), MannKind (NASDAQ:MNKD), Republic Services (NYSE:RSG), American Apparel (NYSEMKT:APP)

William Stanley, Director at American Realty Capital Properties Inc. (NASDAQ:ARCP), bought 18,000 shares of Common Stock on 25 June, paying a price of $12.39 per share. American Realty Capital Properties Inc (NASDAQ:ARCP) stock performance was 0.24% in last session and finished the day at $12.44. Traded volume was 5.47million shares in the last session and the average volume of the stock remained 15.10million shares. American … Continue reading Recent Insider Buying: American Realty Capital Properties (NASDAQ:ARCP), MannKind (NASDAQ:MNKD), Republic Services (NYSE:RSG), American Apparel (NYSEMKT:APP)

Unusual Volume at bioetch stocks: CASI Pharmaceuticals (NASDAQ:CASI), Codexis (NASDAQ:CDXS), China Biologic Products (NASDAQ:CBPO), Revance Therapeutics (NASDAQ:RVNC), Oncolytics Biotech, (NASDAQ:ONCY)

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that its orally-active, Aurora A/angiogenic kinase inhibitor, ENMD-2076, has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of hepatocellular carcinoma (HCC). CASI Pharmaceuticals Inc (NASDAQ:CASI) stock performance was -4.79% in last session and finished the day at $1.85. … Continue reading Unusual Volume at bioetch stocks: CASI Pharmaceuticals (NASDAQ:CASI), Codexis (NASDAQ:CDXS), China Biologic Products (NASDAQ:CBPO), Revance Therapeutics (NASDAQ:RVNC), Oncolytics Biotech, (NASDAQ:ONCY)

Top Gainers: TherapeuticsMD (NYSEMKT:TXMD), Neurometrix (NASDAQ:NURO), Bioamber (NYSE:BIOA), Digital Power Corporation (NYSEMKT:DPW)

In company news, TherapeuticsMD Inc. (NYSEMKT:TXMD) rallied Tuesday after analysts at FBR Capital today initiated coverage of the women’s healthcare company with an Outperform rating. TherapeuticsMD Inc (NYSEMKT:TXMD) stock performance was 32.45% in last session and finished the day at $5.47. Traded volume was 23.15million shares in the last session and the average volume of the stock remained 1.17million shares. The beta of the stock … Continue reading Top Gainers: TherapeuticsMD (NYSEMKT:TXMD), Neurometrix (NASDAQ:NURO), Bioamber (NYSE:BIOA), Digital Power Corporation (NYSEMKT:DPW)

Consumer Goods Active Movers: Tesla Motors Inc (NASDAQ:TSLA), Apple Inc. (NASDAQ:AAPL), Coca-Cola Company (NYSE:KO), Procter & Gamble (NYSE:PG)

Tesla Motors Inc. (NASDAQ:TSLA) was sued in China for trademark infringement in the latest example of the difficulties foreign companies face doing business in the country. Tesla Motors Inc (NASDAQ:TSLA) stock performance was -2.87% in last session and finished the day at $222.66. Traded volume was 5.89million shares in the last session and the average volume of the stock remained 6.54million shares. The beta of … Continue reading Consumer Goods Active Movers: Tesla Motors Inc (NASDAQ:TSLA), Apple Inc. (NASDAQ:AAPL), Coca-Cola Company (NYSE:KO), Procter & Gamble (NYSE:PG)

Healthcare Active Movers: Pfizer Inc. (NYSE:PFE), Arena Pharmaceuticals (NASDAQ:ARNA), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)

CliniWorks today announced a strategic alliance between and Pfizer Inc. (NYSE:PFE) to jointly advance the parties’ respective capabilities in working with healthcare provider organizations to identify and close clinical or quality gaps to improve population health. The two companies are partnering to develop a population health management platform solution that leverages CliniWorks’ technologies in disparate data aggregation and Natural Language Processing (which interprets free text … Continue reading Healthcare Active Movers: Pfizer Inc. (NYSE:PFE), Arena Pharmaceuticals (NASDAQ:ARNA), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)